Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Adriana Weinberg, M.D., Mona Rigaud, M.D., Petronella Muresan, M.S., Philip LaRussa, M.D., Patrick Jean-Philippe, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, William Borkowsky, M.D. T-cell phenotypes and responses to vaccines in severely immunocompromised HIV-infected children initiating HAART in PACTG 1006. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Conference

14th Conference on Retroviruses and Opportunistic Infections

Study

P1006
K Rough, GR Seage III, PL Williams, S Hernandez-Diaz, Y Huo, EG Chadwick, RM Hoffman, E Barr, ED Shapiro, K Patel. TDF/FTC in pregnancy shows no increase in adverse infant birth outcomes in US cohorts. Presented at: CROI 2018.

Conference

CROI 2018

Study

P1025
K Rough, GR Seage III, PL Williams, S Hernandez-Diaz, Y Huo, EG Chadwick, RM Hoffman, E Barr, ED Shapiro, K Patel. TDF/FTC in pregnancy shows no increase in adverse infant birth outcomes in US cohorts. Presented at: CROI 2017; 2017 Feb 16.

Conference

CROI 2017
JD Momper, B Best, J Wang, A Stek, TR Cressey, S Burchett, R Kreitchmann, DE Shapiro, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick, IMPAACT P1026s Protocol team. Tenofovir alafenamide pharmacokinetics with and without cobicistat in pregnancy. Presented at: CROI 2018.

Conference

CROI 2018

Study

P1026S
Tenofovir Disoproxil Fumarate (TDF) Pharmacokinetics (PK) with Daily Dosing in the First Week of Life (HPTN 057). Presented at: XIX International AIDS Conference.

Conference

XIX International AIDS Conference
Tenofovir Disoproxil Fumarate (TDF) Pharmacokinetics (PK) with Increased Doses in HIV-1 Infected Pregnant Women and their Newborns (HPTN 057).
PM Murnane, P Bacchetti, JS Currier, S Brummel, H Okochi, N Phung, K Kuncze, R Hoffman, T Nematadzira, D Soko, M Owor, F Saidi, PM Flynn, MG Fowler, M Gandhi. Tenofovir hair levels rise over the postpartum period and highly predict viral loads. Presented at: CROI 2019; 2019 Mar 07.

Conference

CROI 2019

Study

1077BF
Jennifer R. King, Pharm.D., Ram Yogev, M.D., Andrew A. Wiznia, M.D., Bobbie L. Graham, B.S., Vincent J. Carey, Ph.D., Paula Britto, M.S., Patrick Jean-Philippe, M.D., Eric K. Stets, B.S., Edward P. Acosta, Pharm.D. Tenofovir pharmacokinetics across three tenofovir-based antiretroviral regimens in HIV-infected children and adolescents. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.

Conference

10th Int'l Workshop on Clinical Pharmacology of HIV Therapy
Sandra K. Burchett, M.D., M.S., Brookie M. Best, Pharm.D., Mark Mirochnick, M.D., ChengCheng Hu, Ph.D., Edmund Capparelli, Pharm.D., Diane Holland, M.Phil., Elizabeth (Betsy) Smith, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Alice M. Stek, M.D. Tenofovir pharmacokinetics during pregnancy, at delivery and postpartum. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Conference

14th Conference on Retroviruses and Opportunistic Infections

Study

P1026S
Tenofovir population pharmacokinetics in HIV-infected children and adolescents.